THTX

THTX

USD

Theratechnologies Inc. Common Shares

$2.550-0.020 (-0.778%)

Preço em tempo real

Healthcare
Biotecnologia
Canadá

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$2.570

Máximo

$2.590

Mínimo

$2.530

Volume

0.20M

Fundamentos da empresa

Capitalização de mercado

118.1M

Setor

Biotecnologia

País

Canada

Estatísticas de negociação

Volume médio

3.01M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $1.12Atual $2.550Máximo $3.13

Notícias relacionadas

GlobeNewswire

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) --

Ver mais
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
GlobeNewswire

Theratechnologies Provides Update on Sale Process

MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a commercial-stage biopharmaceutical company, today announced that following careful

Ver mais
Theratechnologies Provides Update on Sale Process
BusinessWire

Soleus Capital Issues Letter to The Board of Theratechnologies

Soleus Capital Management, L.P. ("Soleus Capital"), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (NASDAQ:THTX) (the "Company"), today sent a letter to the Board of

Ver mais
Soleus Capital Issues Letter to The Board of Theratechnologies
GlobeNewswire

Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

MONTREAL, April 11, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a commercial-stage biopharmaceutical company, wishes to address its shareholders in

Ver mais
Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company
BusinessWire

Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value

Future Pak, LLC ("Future Pak") today announced that it has submitted two formal proposals since January to acquire all outstanding shares of common stock of Theratechnologies Inc. ("Theratechnologies") (NASDAQ:THTX).

Ver mais
Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value